{"nct_id":"NCT02039505","title":"Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitis","status":"COMPLETED","status_verified_date":"2019-04","start_date":"2014-02-04","start_date_type":"ACTUAL","primary_completion_date":"2018-02-27","primary_completion_date_type":"ACTUAL","completion_date":"2018-06-28","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}